tiprankstipranks
Trending News
More News >
Blade Air Mobility (BLDE)
NASDAQ:BLDE
US Market
Advertisement

Blade Air Mobility (BLDE) AI Stock Analysis

Compare
1,015 Followers

Top Page

BLDE

Blade Air Mobility

(NASDAQ:BLDE)

Rating:55Neutral
Price Target:
$4.50
▲(9.22% Upside)
Blade Air Mobility's overall score is primarily driven by the positive strategic shift highlighted in the earnings call, focusing on the Medical division's growth. However, financial performance challenges, including negative profitability and cash flow issues, weigh down the score. Technical indicators provide a balanced outlook, while valuation remains a concern due to negative earnings.
Positive Factors
Earnings
Blade reported a solid Q4’24 top line beat via its Passenger segment while tight OpEx control drove a narrower than expected EBITDA loss in the seasonally weak quarter.
Market Position
Blade is taking market share from legacy sub-scale service providers, while longer flights and an expanded pool of donor organs via technological innovation drive volume growth.
Profitability
Swift internal improvements led to its first ever year of EBITDA profitability, and drivers behind this will continue and be supplemented by high margin, newly owned aircraft.
Revenue Growth
The FY25 outlook is favorable with mid-to-high single digit revenue growth and margin expansion via contributions from the owned fleet.
Negative Factors
Market Exit
Q4’24 revenue grew a healthy 15% YoY despite a (7%) headwind from its exit of Canadian operations, and both the Medical and Passenger segments saw YoY segment-level EBITDA improve by $2.5M+.
Valuation
Analyst believes Blade remains undervalued on the current year outlook alone, and materially undervalued when considering the multiple catalysts which could drive further profitability growth and TAM expansion in FY26+.

Blade Air Mobility (BLDE) vs. SPDR S&P 500 ETF (SPY)

Blade Air Mobility Business Overview & Revenue Model

Company DescriptionBlade Air Mobility, Inc. (BLDE) is a technology-driven urban air mobility company that provides short-distance aviation services. It focuses on offering cost-effective, time-saving alternatives to ground transportation in congested urban areas. Blade's core services include air transportation using helicopters and seaplanes for routes such as airport transfers, commuter flights, and leisure travel. The company operates across several key markets and is committed to transitioning its fleet to electric vertical takeoff and landing (eVTOL) aircraft as technology and regulatory environment permit.
How the Company Makes MoneyBlade Air Mobility primarily generates revenue through ticket sales for its air transportation services. The company operates on a per-seat booking model, allowing customers to purchase individual seats on scheduled flights or charter entire aircraft for private use. Blade also earns income from its partnerships with operators and manufacturers of aircraft, enhancing its service offerings and expanding its geographic reach. Additionally, Blade capitalizes on its technology platform that optimizes route scheduling and customer booking experiences, which can result in operational efficiencies and customer loyalty. Collaborations with real estate developers and hospitality providers also contribute to its revenue by integrating Blade's services into luxury travel and urban development projects.

Blade Air Mobility Earnings Call Summary

Earnings Call Date:Aug 05, 2025
(Q2-2025)
|
% Change Since: -7.00%|
Next Earnings Date:Nov 05, 2025
Earnings Call Sentiment Positive
The earnings call highlighted significant strategic moves, particularly the sale of the Passenger business to Joby Aviation, which positions the company for focused growth in the Medical division. The Medical division showed strong revenue growth and future potential, supported by strategic partnerships and cash reserves. However, challenges in the Passenger segment and increased maintenance costs slightly dampened the overall positive outlook.
Q2-2025 Updates
Positive Updates
Sale of Blade Passenger Business to Joby Aviation
Blade announced the sale of its Passenger business to Joby Aviation for up to $125 million. This transaction is aimed at unlocking the full potential of Blade's Medical division, which has grown to approximately 60% of revenue and 85% of segment's adjusted EBITDA.
Strong Performance of Medical Division
Medical revenue accelerated its growth to 18% in Q2 2025 versus the prior year period. Medical revenues rose 17.6% year-over-year to a record $45.1 million in Q2 2025. The Medical segment adjusted EBITDA margin increased to 13.4% in Q2 2025 from 11.4% in Q1 2025.
Positive Outlook and Strategic Partnership
Blade's Medical division is entering a long-term partnership with Joby Aviation to gain access to Joby's eVTOL aircraft for medical use. The company plans to focus on organic growth and strategic acquisitions supported by approximately $200 million of cash.
Improvement in Passenger Segment Profitability
Despite challenges, Passenger segment adjusted EBITDA tripled year-over-year from $0.8 million to $2.4 million. The Passenger segment flight margin rose 580 basis points year-over-year to 30.5% in Q2 2025.
Negative Updates
Challenges in U.S. Short Distance Revenue
U.S. Short Distance revenue decreased 5.5% year-over-year, driven by incidents like the New York Tourist helicopter incident in April 2025 and inclement weather in June.
Increased Maintenance Costs Impacting Margins
Medical segment adjusted EBITDA margin declined 100 basis points compared to Q2 2024 due to maintenance downtime and costs. Elevated maintenance events impacted fleet uptime and financial results.
Jet & Other Revenue Decline
Jet & Other revenue decreased 2% year-over-year due to a modest reduction in flight volume and revenue per flight.
Company Guidance
During the Blade Air Mobility Fiscal Second Quarter 2025 Earnings Release Conference Call, significant guidance was provided regarding the company's strategic transformation. Blade announced the sale of its Passenger business to Joby Aviation for up to $125 million, marking a pivotal shift to focus solely on its Medical division, which will be renamed Strata Critical Medical. This transition is expected to enhance value creation, as the Medical segment has grown from 12% of revenue in 2020 to approximately 60% in 2024, contributing to 85% of Blade's adjusted EBITDA. The Medical segment's revenue rose by 17.6% year-over-year to $45.1 million in Q2 2025, with adjusted EBITDA margins improving from 11.4% in Q1 to 13.4% in Q2. Blade expects the sale to be EBITDA and free cash flow neutral, with approximately $7 million in corporate cost efficiencies anticipated. The company aims for mid-teens revenue growth in the latter half of 2025, and has a robust $200 million cash position post-sale to support strategic acquisitions. Strata's leadership team, including Co-CEOs Melissa Tomkiel and Will Heyburn, will focus on executing a disciplined capital allocation strategy to drive organic and inorganic growth, with potential additional proceeds of up to $35 million contingent on employee retention and financial metrics.

Blade Air Mobility Financial Statement Overview

Summary
Blade Air Mobility shows revenue growth but struggles with profitability, indicated by negative net income and EBIT. The balance sheet is stable with good equity levels, yet cash flow management needs improvement to support sustainable growth.
Income Statement
45
Neutral
Blade Air Mobility's revenue has shown growth over the years, with a notable increase in gross profit margin from earlier years. However, the company has faced persistent challenges in profitability, indicated by negative EBIT and net profit margins. The TTM data shows slight improvements in gross profit margins, but the net income remains negative, reflecting ongoing operational challenges.
Balance Sheet
55
Neutral
The company maintains a healthy equity position with a high equity ratio, indicating strong financial structure. However, the debt-to-equity ratio is manageable, suggesting moderate leverage. The return on equity remains negative, reflecting profitability challenges, but the balance sheet is stable with adequate liquidity.
Cash Flow
40
Negative
Blade Air Mobility's cash flows have improved in the TTM with positive operating cash flow. However, the free cash flow remains negative due to high capital expenditures. The operating cash flow to net income ratio is favorable, but the company needs to manage its cash flow more effectively to achieve positive free cash flow.
BreakdownTTMDec 2024Dec 2023Dec 2022Dec 2020Dec 2019
Income Statement
Total Revenue254.34M248.69M225.18M146.12M23.43M31.20M
Gross Profit62.14M58.92M42.12M22.27M2.33M4.70M
EBITDA-18.16M-27.96M-68.12M-69.87M-9.63M-11.07M
Net Income-18.98M-27.31M-56.08M-27.26M-10.16M-10.84M
Balance Sheet
Total Assets257.92M256.68M294.94M325.02M17.71M276.26M
Cash, Cash Equivalents and Short-Term Investments113.42M127.14M166.14M194.04M12.16M276.26M
Total Debt8.84M9.32M24.52M18.33M1.89M0.00
Total Liabilities34.82M34.74M60.64M50.54M6.63M0.00
Stockholders Equity223.10M221.94M234.30M274.49M11.08M0.00
Cash Flow
Free Cash Flow-19.55M-35.51M-34.46M-37.86M-11.20M-11.16M
Operating Cash Flow1.29M-2.52M-32.35M-37.13M-10.82M-10.30M
Investing Cash Flow40.42M-1.02M17.09M79.34M-377.00K-1.05M
Financing Cash Flow-9.99M-5.76M-76.00K-1.08M1.18M116.00K

Blade Air Mobility Technical Analysis

Technical Analysis Sentiment
Neutral
Last Price4.12
Price Trends
50DMA
4.10
Positive
100DMA
3.55
Positive
200DMA
3.66
Positive
Market Momentum
MACD
0.04
Negative
RSI
49.41
Neutral
STOCH
50.73
Neutral
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For BLDE, the sentiment is Neutral. The current price of 4.12 is below the 20-day moving average (MA) of 4.19, above the 50-day MA of 4.10, and above the 200-day MA of 3.66, indicating a neutral trend. The MACD of 0.04 indicates Negative momentum. The RSI at 49.41 is Neutral, neither overbought nor oversold. The STOCH value of 50.73 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Neutral sentiment for BLDE.

Blade Air Mobility Risk Analysis

Blade Air Mobility disclosed 64 risk factors in its most recent earnings report. Blade Air Mobility reported the most risks in the "Finance & Corporate" category.
Finance & Corporate - Financial and accounting risks. Risks related to the execution of corporate activity and strategy
Latest Risks Added 1 New Risks

Blade Air Mobility Peers Comparison

Overall Rating
UnderperformOutperform
Sector (65)
Financial Indicators
Name
Overall Rating
Market Cap
P/E Ratio
ROE
Dividend Yield
Revenue Growth
EPS Growth
65
Neutral
$2.66B15.2815.18%3.69%0.27%26.17%
55
Neutral
$336.59M-8.39%6.70%63.35%
54
Neutral
$279.65M28.8626.01%
53
Neutral
$47.31M-378.73%-14.62%-86.07%
50
Neutral
$1.26B-2416.94%-20.21%88.09%
47
Neutral
$189.72M138.02%-3.95%85.63%
41
Neutral
$8.25M-398.23%-9.49%97.34%
* Industrials Sector Average
Performance Comparison
Ticker
Company Name
Price
Change
% Change
BLDE
Blade Air Mobility
4.17
1.06
34.08%
MESA
Mesa Air Group
1.18
-0.11
-8.53%
UP
Wheels Up Experience
1.81
-0.17
-8.59%
FLYX
flyExclusive
3.97
-0.09
-2.22%
SOAR
Volato Group
1.50
-9.25
-86.05%
SRFM
Surf Air Mobility, Inc.
4.38
2.45
126.94%

Blade Air Mobility Corporate Events

Executive/Board ChangesM&A TransactionsBusiness Operations and Strategy
Blade Air Mobility Sells Passenger Division to Joby
Neutral
Aug 4, 2025

On August 1, 2025, Blade Air Mobility entered into an agreement to sell its passenger division to Joby Aviation for up to $125 million. This transaction will allow Blade to focus on its medical services division, which will be rebranded as Strata Critical Medical, emphasizing its logistics and medical services. The divestiture is expected to be financially neutral and will enable Blade, now Strata, to access Joby’s eVTOL aircraft for medical transport, enhancing its service offerings. The management transition will see Rob Wiesenthal moving to Joby, while Will Heyburn and Melissa Tomkiel will become co-CEOs of Strata.

The most recent analyst rating on (BLDE) stock is a Buy with a $6.50 price target. To see the full list of analyst forecasts on Blade Air Mobility stock, see the BLDE Stock Forecast page.

Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: Aug 14, 2025